Day 2

PROMUS PREMIER: new everolimus-eluting stent

solaci
solaci
426
0

The study aims to evaluate clinical, angiographic and IVUS results of the new platinum chromium everolimus stent. The new design of the device has additional proximal connectors to enhance the longitudinal strength where distortion is more common. Included were 100 patients with de novo coronary lesions and a reference diameter of 2.5 to 4 mm and a length of

Conclusion: Technical success was high with clinical, angiographic and IVUS showing safety and efficacy without observing any stent deformation.

john_ormistron_europcr
John Ormistron.
2013-05-22

Original title: Clinical, angiographic and IVUS outcomes of the NG PROMUS clinical trial evaluating the novel Promus PREMIER stent. 

Previous article
PRAGUE 19: bioabsorbable platform for patients with ST segment elevation
Next article
HATTRICK-OCT: biodegradable polymer struts coverage versus permanent
solaci
solaci

More articles by this author

REPRISE II: results obtained with the new valve according to VARC criteria

solaci - 0
The objective was to evaluate the safety and efficacy of the Lotus Valve System to treat patients with severe aortic stenosis and high surgical...

DEFLECT I: cerebral protection device in TAVI

solaci - 0
Strokes after TAVI occur in between 3.8 and 6.7% of the cases, with new MRI lesions being almost the rule. The TriGuard EDD device...

DISCOVER: new low profile valve with little post-implant regurgitation

solaci - 0
The objective of the study was to assess events after 30 days with the DirectFLOW Medical Valve device in patients with severe aortic stenosis...

JUPITER: transapical TAVI device

solaci - 0
We evaluated 88 consecutive patients (at this phase) with severe aortic stenosis who received the second-generation device for transapical access. Survival at thirty days...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 2

REPRISE II: results obtained with the new valve according to VARC criteria

The objective was to evaluate the safety and efficacy of the Lotus Valve System to treat patients with severe aortic...
solaci -
SOLACI Sessionsspot_img

Recent Articles

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Dr. Omar Tupayachi - 0
Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Dr. Andrés Rodríguez - 0
Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Dr. Juan Manuel Pérez - 0
Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...